Eagle Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,596
Closed -$1.88M 566
2023
Q2
$1.88M Sell
3,596
-3,349
-48% -$1.75M 0.01% 446
2023
Q1
$4M Sell
6,945
-3,753
-35% -$2.16M 0.02% 370
2022
Q4
$5.92M Sell
10,698
-2,655
-20% -$1.47M 0.04% 308
2022
Q3
$6.77M Sell
13,353
-272
-2% -$138K 0.04% 295
2022
Q2
$7.4M Sell
13,625
-500
-4% -$272K 0.05% 287
2022
Q1
$8.34M Sell
14,125
-1,517
-10% -$896K 0.04% 304
2021
Q4
$10.4M Buy
15,642
+406
+3% +$270K 0.05% 303
2021
Q3
$8.7M Buy
15,236
+2,564
+20% +$1.46M 0.04% 339
2021
Q2
$6.39M Sell
12,672
-8,274
-40% -$4.17M 0.03% 390
2021
Q1
$9.56M Buy
20,946
+20,142
+2,505% +$9.19M 0.04% 325
2020
Q4
$374K Sell
804
-19,613
-96% -$9.12M ﹤0.01% 480
2020
Q3
$8.87M Buy
20,417
+4,720
+30% +$2.05M 0.05% 299
2020
Q2
$5.51M Sell
15,697
-6,278
-29% -$2.2M 0.03% 363
2020
Q1
$6.23M Buy
21,975
+68
+0.3% +$19.3K 0.04% 338
2019
Q4
$7.12M Sell
21,907
-63
-0.3% -$20.5K 0.03% 357
2019
Q3
$6.4M Sell
21,970
-128
-0.6% -$37.3K 0.03% 369
2019
Q2
$6.49M Buy
22,098
+4,622
+26% +$1.36M 0.03% 374
2019
Q1
$4.78M Buy
17,476
+224
+1% +$61.3K 0.03% 416
2018
Q4
$3.86M Sell
17,252
-159
-0.9% -$35.6K 0.02% 421
2018
Q3
$4.25M Buy
17,411
+498
+3% +$122K 0.02% 450
2018
Q2
$3.5M Buy
16,913
+310
+2% +$64.2K 0.02% 464
2018
Q1
$3.43M Buy
16,603
+79
+0.5% +$16.3K 0.02% 473
2017
Q4
$3.43M Sell
16,524
-126
-0.8% -$26.2K 0.02% 478
2017
Q3
$3.19M Sell
16,650
-127
-0.8% -$24.3K 0.02% 488
2017
Q2
$2.93M Sell
16,777
-8
-0% -$1.4K 0.02% 493
2017
Q1
$2.58M Buy
16,785
+425
+3% +$65.3K 0.02% 526
2016
Q4
$2.31M Buy
+16,360
New +$2.31M 0.02% 534
2013
Q3
Sell
-36,494
Closed -$3.09M 709
2013
Q2
$3.09M Buy
+36,494
New +$3.09M 0.02% 546